Lavipharm S.A. (LAVI.AT)

EUR 0.87

(-0.35%)

Total Liabilities Summary of Lavipharm S.A.

  • Lavipharm S.A.'s latest annual total liabilities in 2023 was 72.07 Million EUR , down -2.65% from previous year.
  • Lavipharm S.A.'s latest quarterly total liabilities in 2024 Q2 was 72.43 Million EUR , up 0.5% from previous quarter.
  • Lavipharm S.A. reported annual total liabilities of 74.03 Million EUR in 2022, up 17.67% from previous year.
  • Lavipharm S.A. reported annual total liabilities of 62.92 Million EUR in 2021, up 0.45% from previous year.
  • Lavipharm S.A. reported quarterly total liabilities of 72.07 Million EUR for 2023 FY, down -2.65% from previous quarter.
  • Lavipharm S.A. reported quarterly total liabilities of 72.07 Million EUR for 2023 Q4, down -4.37% from previous quarter.

Annual Total Liabilities Chart of Lavipharm S.A. (2023 - 2016)

Historical Annual Total Liabilities of Lavipharm S.A. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 72.07 Million EUR -2.65%
2022 74.03 Million EUR 17.67%
2021 62.92 Million EUR 0.45%
2020 62.64 Million EUR -2.51%
2019 64.25 Million EUR 4.66%
2018 61.39 Million EUR -5.31%
2017 64.83 Million EUR -38.62%
2016 105.63 Million EUR 0.0%

Peer Total Liabilities Comparison of Lavipharm S.A.

Name Total Liabilities Total Liabilities Difference